As thousands of attendees get ready to descend on Las Vegas in a couple weeks for CES 2022 and its latest and greatest technology innovation reveals, we wanted to give you a sneak peek behind the EarlySense curtain – and what we’ve got planned for the world’s largest technology show.
Award-winning Technology Reveal
Available for viewing in a couple locations, we will be showcasing our not-yet-available InSight+® sensing technology system, which snagged a coveted CES® 2022 Innovation Awards Honoree title this fall.
The award-winning solution will be available to view in the following places:
- In the Innovation Awards Showcase at the Venetian Expo (Halls A-C);
- At the CONNECTED Health Summit Reception at Treasure Island; and
- By appointment in the company’s CES Exhibit Suite at the Venetian (29-221).
“We’re really looking forward to unveiling this new technology to attendees at the show,” said Matt Johnson, CEO of EarlySense. “With the pandemic still with us, we know we will continue to see an explosion in use cases for patients who want to be cared for at home and for providers who want to incorporate virtual care solutions into their practices in the long-term.”
The Inside Scoop on InSight +
The EarlySense InSight+ system (an investigational device not yet available for sale) is built on the company’s medical-grade technology and re-engineered for the home. It utilizes a contact-free, under-the-mattress sensor to continuously and passively collect patient vital signs, sleep and movement data. A cellular hub securely transmits that data to the EarlySense cloud, where it can be integrated into care management systems and dashboards.
The data collected from patients through the InSight+ sensor includes sleep stages, sleep trends, sleep scoring, overnight breathing patterns, heart rate, heart rate variability, respiratory rate, respiratory rate variability and body movement levels.
Using years of data from its monitoring solutions in hospitals as a baseline, the solution applies smart pattern detection and Artificial Intelligence (AI) models to flag subtle shifts in patient vital signs and core biometrics, with the intent to help healthcare providers visualize clinical marker changes and flag early signs of patient deterioration.
Available for Clinical Partners
Not scheduled to be made broadly available until the second half of 2022, EarlySense is making the new InSight+ systems available as part of its Clinical Development Partner Program, giving early access to the proprietary monitoring technology to augment ongoing clinical development efforts.
“We’re truly excited by the opportunity to partner with researchers, technology developers and clinical service providers who are as passionate about advancing in-home virtual care solutions as we are,” said Terry Duesterhoeft, Chief Product & Innovation Officer of EarlySense. “This initiative will allow us to support studies and develop new applications to provide a fuller picture of true patient health, with vital sign data captured continuously overnight – the time when it is most stable to gather data.”